Esmya FDA Approval Status
FDA Approved: No
Brand name: Esmya
Generic name: ulipristal acetate
Company: Allergan plc
Treatment for: Uterine Fibroids
Esmya (ulipristal acetate) is an oral selective progesterone receptor modulator (SPRM) in development for the treatment of uterine fibroids.
Development timeline for Esmya
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.